Literature DB >> 28981183

Importance of lymph node ratio for locoregional recurrence of squamous cell carcinoma of the buccal mucosa.

Ali-Farid Safi1,2, Andrea Grandoch1,2, Hans-Joachim Nickenig1,2, Joachim E Zöller1,2, Matthias Kreppel1,2.   

Abstract

BACKGROUND: There is no published study on the influence of lymph node ratio on locoregional recurrence of squamous cell carcinoma (SCC) of the buccal mucosa. Therefore, we focused in our study on this specific anatomic subsite.
METHODS: We conducted a retrospective chart review of 95 patients from 2003-2013 with treatment-naive SCC of the buccal mucosa. Exclusion criteria were neoadjuvant chemoradiotherapy, perioperative death, N3 disease, unresectable disease, synchronous malignancy, and follow-up <3 months. Statistical analysis was performed using univariate and multivariate analysis.
RESULTS: Significant correlations were found between locoregional recurrence and pathologic N classification (P < .001), grading (P = .001), and lymph node ratio (P < .001). Multivariate analysis indicated lymph node ratio as an independent risk factor for locoregional recurrence (P = .002). A cutoff value under 7% led to a 10.383-fold higher risk of incurring a locoregional recurrence.
CONCLUSION: Lymph node ratio is a useful parameter to stratify the risk of locoregional recurrence in patients with SCC of the buccal mucosa.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  buccal mucosa; locoregional recurrence; lymph node ratio; multivariate analysis; risk factors

Mesh:

Year:  2017        PMID: 28981183     DOI: 10.1002/hed.24922

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  A novel histopathological scoring system for patients with oral squamous cell carcinoma.

Authors:  Ali-Farid Safi; Kathrin Grochau; Uta Drebber; Volker Schick; Oliver Thiele; Tim Backhaus; Hans-Joachim Nickenig; Joachim E Zöller; Matthias Kreppel
Journal:  Clin Oral Investig       Date:  2019-01-23       Impact factor: 3.573

2.  Oral Cancer: Integration of Studies for Diagnostic and Therapeutic Precision.

Authors:  N J D'Silva; J S Gutkind
Journal:  Adv Dent Res       Date:  2019-11

3.  Towards an Improved Pathological Node Classification for Prognostic Stratification of Patients With Oral Cavity Squamous Cell Carcinoma: Results From a Nationwide Registry Study.

Authors:  Chung-Jan Kang; Yu-Wen Wen; Shu-Ru Lee; Shu-Hang Ng; Chi-Ying Tsai; Li-Yu Lee; Ying-Hsia Chu; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Chia-Hsun Hsieh; Chih-Hua Yeh; Chih-Hung Lin; Chung-Kan Tsao; Tuan-Jen Fang; Shiang-Fu Huang; Li-Ang Lee; Ku-Hao Fang; Yu-Chien Wang; Wan-Ni Lin; Li-Jen Hsin; Tzu-Chen Yen; Nai-Ming Cheng; Chun-Ta Liao
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

4.  Elective neck dissection versus wait-and-see policy in cT1N0 buccal squamous cell carcinoma.

Authors:  Qigen Fang; Hua Gao; Qing Gao; Jinlan Sun; Peng Li; Meng Cui; Enxi Zhang; Wenlong Yin; Yuanyuan Dong
Journal:  BMC Cancer       Date:  2020-06-09       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.